IF
BBH icon

Integrity Financial’s VanEck Biotech ETF BBH Stock Holding History

Integrity Financial’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Buy
+664
New +$128K 0.06% 178
2023
Q4 		– Sell
-664
Closed -$103K – 198
2023
Q3 		$103K Buy
+664
New +$106K 0.08% 124

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Integrity Financial's BBH Position: Q1 2026 in Review

Integrity Financial opened a new position in VanEck Biotech ETF (BBH) in Q1 2026: 664 shares worth $125K. The stake represents 0.06% of the portfolio and ranks #178 among its holdings. This is a return to the name: Integrity Financial previously reported a position in BBH as recently as Q3 2023.

Integrity Financial first reported a position in BBH in Q3 2023 and has held it in 2 quarters since. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Integrity Financial held 664 shares of VanEck Biotech ETF worth $125K as of Q1 2026.
  • VanEck Biotech ETF was a new Integrity Financial position in Q1 2026.
  • VanEck Biotech ETF made up 0.06% of Integrity Financial's portfolio in Q1 2026, its #178 holding.
  • Integrity Financial first reported a position in VanEck Biotech ETF in Q3 2023 and has held it in 2 quarters since.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Integrity Financial's 13F filing for Q1 2026, filed 14 May 2026.